- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
104 CHAPTER 3 Bladder outlet obstruction
Bladder outlet obstruction and retention in women
In women this condition is relatively rare (~5% of women undergoing pressure-flow studies have BOO, compared with 60% of unselected men with LUTS).1
It may be symptom-free, present with LUTS or as acute urinary retention. In broad terms, the causes are related to obstruction of the urethra (e.g., urethral stricture, compression by a prolapsing pelvic organ such as the uterus, post-surgery for stress incontinence) or have a neurological basis (e.g., injury to sacral cord or parasympathetic plexus, degenerative neurological disease, e.g., MS, diabetic cystopathy).
Voiding studies in women
Women have a higher Qmax (maximal flow), for a given voided volume than that of men. Women with BOO have lower Qmax than those without BOO. There are no universally accepted urodynamic criteria for diagnosing BOO in women.
Treatment of BOO in women
Treat the cause (e.g., dilatation of a urethral stricture; repair of a pelvic prolapse). Where this is not possible (because of a neurological cause such as MS or spinal cord injury), the options are as follows:
•Intermittent self-catheterization (ISC) or intermittent catheterization by a caregiver
•Indwelling catheter (preferably suprapubic rather than urethral)
•Mitrofanoff catheterizable stoma
Where urethral intermittent self-catheterization is technically difficult, a catheterizable stoma can be constructed between the anterior abdominal wall and the bladder, using the appendix, Fallopian tube, or a narrowed section of small intestine, known collectively as the Mitrofanoff procedure. It is simply a new urethra that has an abdominal location, rather than a perineal one, and is therefore easier to access for ISC.
For women with a suprasacral spinal cord injury with preserved detrusor contraction and urinary retention due to detrusor-sphincter dyssynergia (DSD), sacral deafferentation combined with a Brindley stimulator can be used to manage the resulting urinary retention.
Fowler syndrome
Fowler syndrome is a primary disorder of sphincter relaxation (as opposed to secondary to, for example, SCI). Increased electromyographic (EMG) activity (repetitive discharges on external sphincter EMG) can be recorded in the external urethral sphincters of these women (which on ultrasound are of increased volume) and is hypothesized to cause impaired relaxation of external sphincter.
It occurs in premenopausal women, typically aged 15–30, often in association with polycystic ovaries (50% of patients), acne, hirsutism, and menstrual irregularities. It may also be precipitated by childbirth, gynecological or other surgical procedures.
BLADDER OUTLET OBSTRUCTION AND RETENTION IN WOMEN 105
Patients report no urgency with bladder volumes >1000 mL, but when attempts are made to manage their retention by ISC, they experience pain, especially on withdrawing the catheter.
Pathophysiology
Fowler may be due to a channelopathy of the striated urethral sphincter muscle leading to involuntary external sphincter contraction.
Treatment
Treatment is with ISC, sacral neuromodulation with Medtronic InterStim (90% void post-implantation and 75% are still voiding at 3-year follow-up). The mechanism of action of sacral neuromodulation in urinary retention is unknown.
Further reading
Swinn MJ, Fowler C, et al. (2002). The cause and treatment of urinary retention in young women. J Urol 167:151–156.
1 Madersbascher S, Pycha A, Klingler CH, et al. (1998). The aging lower urinary tract: a comparative urodynamic study of men and women. Urology 51:206–212.
106 CHAPTER 3 Bladder outlet obstruction
Urethral stricture disease
A urethral stricture is an area of narrowing in the caliber of the urethra due to formation of scar tissue in the tissues surrounding the urethra. The disease process of anterior urethral stricture disease is different from that in the posterior urethra.
Anterior urethra
The process of scar formation occurs in the spongy erectile tissue (corpus spongiosum) of the penis that surrounds the urethra (spongiofibrosis). Causes include the following:
•Inflammation (e.g., balanitis xerotica obliterans [BXO]), gonococcal infection leading to gonococcal urethritis (less common today because of prompt treatment of gonorrhea)
•Trauma
• Straddle injuries—blow to bulbar urethra (e.g., cross-bar injury)
•Iatrogenic—instrumentation (e.g., traumatic catheterization, traumatic cystoscopy, TURP, bladder neck incision)
The role of nonspecific urethritis (e.g., Chlamydia) in the development of anterior urethral strictures has not been established.
Posterior urethra
Fibrosis of the tissues around the urethra results from trauma—pelvic fracture or surgical (radical prostatectomy, TURP, urethral instrumentation). These are essentially distraction injuries, where the posterior urethra has been pulled apart, and the subsequent healing process results in the formation of a scar, which contracts and thereby narrows the urethral lumen.
Symptoms and signs of urethral stricture
•Voiding symptoms—hesitancy, poor flow, post-micturition dribbling
•Urinary retention—acute, or high-pressure acute-on-chronic
•Urinary tract infection—prostatitis, epididymitis
Management of urethral strictures
When the patient presents with urinary retention, the diagnosis is usually made following a failed attempt at urethral catheterization. In such cases, avoid the temptation to blindly dilate the urethra. Dilatation may be the wrong treatment option for this type of stricture—it may convert a short stricture that could have been cured by urethrotomy or urethroplasty into a longer and denser stricture, thus committing the patient to more complex surgery and a higher risk of recurrent stricturing. Place a suprapubic catheter instead, and image the urethra with retrograde and antegrade urethrography to establish the precise position and the length of the stricture.
Similarly, avoid the temptation to inappropriately dilate a urethral stricture diagnosed at flexible cystoscopy (urethroscopy). Arrange retrograde urethrography so appropriate treatment can be planned.
URETHRAL STRICTURE DISEASE 107
Treatment options
Urethral dilatation
This is designed to stretch the stricture without causing more scarring; bleeding post-dilatation indicates tearing of the stricture (i.e., further injury has been caused) and restricturing is likely.
Internal (optical) urethrotomy
This procedure involves stricture incision, with an endoscopic knife or laser. The stricture is divided, followed by epithelialization of the incision. If deep spongiofibrosis is present, the stricture will recur.
It is best suited for short (<1.5 cm) bulbar urethral strictures with minimal spongiofibrosis.1 Leave a catheter for 3–5 days (longer catheterization does not reduce long-term restricturing).
Consider ISC for 3–6 months, starting several times daily, reducing to once or twice a week toward the end of this period.
Excision and reanastomosis or tissue transfer
Treatment involves excision of the area of spongiofibrosis with primary reanastomosis or closure of defect with buccal mucosa or pedicled skin flap; this has best chance of cure.
A stepwise progression up this reconstructive ladder (the process of starting with a simple procedure and moving onto the next level of complexity when this fails) is not appropriate for every patient. For the patient who wants the best chance of long-term cure, offer excision and reanastomosis or tissue transfer up front.
For the patient who is happy with lifelong management of his stricture (with repeat dilatation or optical urethrotomy), offer dilatation or optical urethrotomy.
Balanitis xerotica obliterans (BXO)
BXO is genital lichen sclerosis and atrophicus in the male. Hyperkeratosis is seen histologically. BXO appears as a white plaque on the foreskin, glans of the penis, or within the urethral meatus. It is the most common cause of stenosis of the meatus.
The foreskin becomes thickened and adheres to the glans, leading to phimosis (a thickened, nonretractile foreskin). Patients with long-standing BXO and meatal stenosis often have more proximal urethral strictures.
1 Pansadoro V, Emiliozzi P (1996). Internal urethrotomy in the management of anterior urethral strictures: long term follow-up. J Urol 156:73–75.
This page intentionally left blank